Ozempic®
Wegovy®
Topiramate
Metformin
*1 year after starting Found, users have lost an avg. of 12% of their body weight. Results are based on data from 1,773 users active for > 1 year & reported their weight weekly on avg. Separately, in a 72-week clinical trial of tirzepatide (15 mg), paired with diet/exercise, patients without diabetes & with BMI ≥30, or BMI ≥27 & a weight-related diagnosis, lost 20% of their body weight in 1 year. RX are up to a medical provider’s discretion & tirzepatide has black box warnings. Certain medications are FDA-approved for conditions other than weight loss. See full risk info below.
From our Chief Medical Officer
“Weight loss is personal. Your prescription plan for your weight loss journey should be personalized as well.”
— Dr. Rekha Kumar, MD
Medication can be an effective solution rather than a last resort. It can work with your biology, instead of against it, to unlock sustainable weight loss.
As seen in
Our clinicians can prescribe two types of medication to help with your weight loss goals.
These oral medications prescribed by Found work by reducing appetite and cravings, regulating insulin, and/or balancing blood sugar.
These injectable and oral GLP-1 medications prescribed by Found mimic the natural hormones in your gut that helps regulate weight.
These oral prescriptions available through Found work by reducing appetite and cravings, regulating insulin, and/or balancing blood sugar.
These injectable and oral GLP-1 medications available through Found mimic the natural hormones in your gut that helps regulate weight.
From our Chief Medical Officer
“At Found, clinicians prescribe medication alternatives that are tailored to your unique goals.”
— Dr. Rekha Kumar, MD
Together, we’ll find the most effective medication plan for your unique biological needs with a supportive, shame-free experience.
*Medication is not included in plus memberships. In-network insurance coverage details,pricing,terms vary. Copays,coinsurance,deductibles may apply. Review offer terms below for more details. RX are up to a medical provider’s discretion.
*In-network insurance coverage details, pricing and terms vary. Copays, coinsurance and deductibles may apply. Review offer terms on www.joinfound.com for more details. Prescriptions are up to a medical provider’s discretion.
As Found's Chief Medical Officer, I help design the clinical protocols that guide the medical care Found's members receive-- care that is guided by the latest advancements in obesity medicine.
As Found's Chief Medical Officer, I help design the clinical protocols that guide the medical care Found's members receive-- care that is guided by the latest advancements in obesity medicine.
*Dr Kumar does not interact directly with Found patients.
Learn about what to expect once you click “Get started”.
Share your health history and weight loss goals. Take the health assessment to see if you qualify for a prescription medication plan and get results.
If you qualify, a board-certified clinician will review your health history and goals to determine the best plan for you.*
You’ll get unlimited access to a network of Found coaches and community for ongoing lifestyle change support.
You'll continue to consult with your care team to make sure treatment is working for you.
*RX are up to a medical provider’s discretion and based on each person’s unique medical history.
Find your most confident, healthy self.
Find your most confident, healthy self.
*Real user, paid for appearance. Individual results may vary. In 1 year, Found users lost an avg. of 12% body weight. Results based on data from 1,773 users who reported their weight at least 1 time/week on avg. for 1 year. RX are up to a medical provider’s discretion. See below for risk info.
The best part about being with Found is I was able to get as close to getting a 6-pack as I as I've ever been and the best part about it is I've been able to do it without doing cardio.
120 pounds down through Found and I no longer have sleep apnea, which is such a relief and I'm sleeping so much better.
I found I'm getting my life back. I am now the best version of myself that I have been in over 20 years.
Together, we'll find the most effective plan for your unique biology and its blockers — to help you lose weight safely and sustainably.
Select your
current weight
250lb.
Weight you
could lose (lb.)
50lb.
Name brand semaglutide carries a Black Box Warning.
Semaglutide is not recommended in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take it if you have ever had thyroid cancer. In studies with rodents, semaglutide caused thyroid tumors, including thyroid cancer; it is not known if it will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking semaglutide.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using semaglutide and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.
Compounded medications are not FDA-approved or evaluated for safety or efficacy but include active ingredients sourced from FDA-registered facilities. If you notice any changes in the appearance, color, or consistency of the medication, please contact your prescriber immediately before using it.
Do not use this medication if you are or suspect you may be allergic to any of the ingredients in the compounded product. Other ingredients include:
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects while taking semaglutide. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with other drugs that may lower blood sugar, such as insulin or insulin secretagogues such as sulfonylureas. Semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (i.e., warfarin) should be monitored closely while on semaglutide. Talk to your health care provider if you are taking levothyroxine before taking semaglutide.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
Tirzepatide, the active ingredient in Zepbound, is contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take it if you have ever had thyroid cancer. In studies with rodents, tirzepatide caused thyroid tumors, including thyroid cancer; it is not known if it will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Zepbound.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Zepbound, as your diabetes medications may need to be adjusted as you lose weight.
People of childbearing age should use reliable birth control while taking this medication. Use a non-oral contraceptive method (instead of an oral contraceptive). If you use oral contraception, add a barrier method of contraception during the first four weeks after initiation and for four weeks after dose escalation.
This medication may cause fetal harm. Do not take this medication if pregnant, trying to get pregnant, or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least two months before trying. Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Zepbound and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Zepbound and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or a very rapid heartbeat.
Severe hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Zepbound if suspected and promptly seek medical advice.
Please get in touch with your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Zepbound can interact with alcohol and some prescription and non-prescription drugs and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Zepbound delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, before starting Zepbound please review the timing of taking it with your prescribing doctor as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (e.g., warfarin) should be monitored closely while on Zepbound.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information.
To report suspected adverse reactions to Zepbound, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergency, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Mounjaro®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Mounjaro®, as your diabetes medications may need to be adjusted as you lose weight.
Females of reproductive potential should use adequate contraception while taking this medication. It is advised to use a non-oral contraceptive method (instead of oral contraceptive) or, if using oral contraception- add a barrier method of contraception 4 weeks after initiation and 4 weeks after dose escalation.
Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Mounjaro® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Mounjaro® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Mounjaro® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Mounjaro® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Mounjaro® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Mounjaro®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted.The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Mounjaro®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Mounjaro® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Wegovy®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Wegovy®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Wegovy® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Wegovy® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Wegovy® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Wegovy® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Wegovy® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Wegovy®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Wegovy®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Wegovy® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Ozempic®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Ozempic®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Ozempic® and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Ozempic® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Ozempic® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Ozempic® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Ozempic®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Ozempic®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Ozempic® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Trulicity®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Trulicity®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Trulicity® and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Trulicity® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Trulicity® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Trulicity® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Trulicity® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Trulicity®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted.The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Trulicity®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Trulicity® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Saxenda®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Saxenda®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Saxenda® and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Saxenda® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Saxenda® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Saxenda® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Saxenda® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Saxenda®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted.The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Saxenda®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Saxenda® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Victoza®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Victoza®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Victoza® and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Victoza® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Victoza® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Victoza® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Victoza® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Victoza®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Victoza®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Victoza® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Rybelsus®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Rybelsus®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Rybelsus® and call your health care provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Rybelsus® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Rybelsus® if suspected and promptly seek medical advice.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
Many people experience no side effects. Some of the most common or potential side effects include:
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
As with other medications, Rybelsus® can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Rybelsus® delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Rybelsus®, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Rybelsus®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Rybelsus® contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
The “black box” on Contrave® warns that this drug may cause suicidal thinking and behavior in young adults, whether or not patients are taking medicines used to treat depression. It may increase the risk of suicidal thoughts in some young adults within the first few months of treatment. Monitor and report worsening or new suicidal thoughts and behaviors to your health care provider. Patients taking bupropion for smoking cessation may also experience changes in mood, psychosis, hallucinations, paranoia, delusions, homicidal ideation, hostility, aggression, anxiety, and panic, as well as suicidal ideation, suicide attempt, and completed suicide, high blood pressure, fast, irregular heartbeats, seizures, acute angle-closure glaucoma, and death.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your health care provider about your medical history prior to taking Contrave®.
The safety and effectiveness of Contrave®, in combination with other products intended for weight loss, including prescription and over-the-counter drugs, and herbal preparations, have not been established.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Contrave®, as your diabetes medications may need to be adjusted as you lose weight.
Do not use this medication if you are or suspect you may be allergic to any of the ingredients in Contrave® including naltrexone and bupropion.
Notify your doctor if you experience:
Stop using Contrave® and get medical help immediately if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Tell your health care provider about your medical history. You should not take Contrave® if you:
You should not take Contrave® under these circumstances either:
If you take opioids or opiates right after stopping Contrave®, you may be more sensitive to them and require lower doses—which poses a risk of overdose. Please talk to your provider before initiating any opioids or opiates after stopping Contrave®.
While some people experience no side effects while taking Contrave®. Some of the most common side effects are:
Additional but less common side effects may include:
Fast heart rate, heart attack, dizziness, motion sickness, lower abdominal pain, gas, lip swelling, rectal bleeding, hernia, inflamed gallbladder, pneumonia, staph infection, kidney infection, increased blood creatinine, increased hepatic enzymes, decreased hematocrit, feeling jittery, feeling abnormal, feeling weak or a loss of energy, thirst, feeling hot, disturbance in attention, feeling sleepy, tremors, balance disorder, impaired memory, amnesia, abnormal dreams, nervousness, feeling spacey, tension, agitation, mood swings, abnormal and frequent urination, dehydration, bulging or herniated discs, jaw pain, feeling faint, hair loss, erectile dysfunction, vaginal dryness, and irregular menstrual cycles (periods).
These symptoms often subside as your body adjusts to the medication. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
If you take diabetes medications, please discuss this with your prescribing clinician before taking Contrave® since your diabetes medications may need to be adjusted as you lose weight.
As with other medications, Contrave® can interact with alcohol and certain prescription and OTC medications and herbal products. Some drugs and other substances can interact with Contrave®, including alcohol, MAOIs (like isocarboxazid, linezolid, phenelzine, selegiline, or tranylcypromine), drugs that increase dopamine levels in your system (like levodopa and amantadine), drugs that affect the central nervous system (like antihistamines or medicine for allergies or colds, sedatives, tranquilizers, or sleeping medication), drugs for depression or anxiety, antipsychotics, theophylline, systemic corticosteroids, prescription pain medicine or narcotics, medicine for attention deficit and hyperactivity disorder (ADHD), medicine for seizures or barbiturates, muscle relaxants, anesthetics, including some dental anesthetics, dextromethorphan, diarrhea medication (such as diphenoxylate), disulfiram, opioid pain or cough relievers (such as codeine and hydrocodone), thioridazine.
Avoid drinking alcohol while taking Contrave®.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information.
To report suspected adverse reactions to Contrave®, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, dizziness, changes in heart rate/rhythm, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. In more than 20,000 patient-years exposure to metformin in clinical trials, there were no reports of lactic acidosis. Reported cases have occurred primarily in diabetic patients with significant renal insufficiency, including both intrinsic renal disease and renal hypoperfusion, often in the setting of multiple concomitant medical/surgical problems and multiple concomitant medications.
Risk factors include renal impairment, concomitant use of certain drugs, age ≥65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, and hepatic impairment. Lactic acidosis is a medical emergency and requires immediate treatment in the hospital.
Before using metformin, tell your health care provider about your medical history, especially if you have:
Talk to your health care provider if you are planning to become pregnant or if pregnant or breastfeeding. Avoid alcohol while taking this medication. Talk to your health care provider about discontinuing metformin prior to a surgical procedure or an iodinated contrast imaging procedure. Stop metformin and notify your health care provider immediately if you have an illness with severe diarrhea and/or vomiting resulting in dehydration.
Many people experience no side effects while taking metformin. The most common side effects of metformin include:
These symptoms may subside after the body adjusts to the medication. Taking your medicine with the evening meal can help reduce these side effects.
Additional but rare side effects include:
DRUG INTERACTIONS
As with other medications, metformin can interact with alcohol and certain medications, including angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, corticosteroids, hormone replacement therapy and estrogens, oral contraceptives, carbonic anhydrase inhibitors, nifedipine, thiazides or furosemide and other diuretics, phenothiazines, phenytoin, nicotinic acid (niacin), multidrug and toxin extrusion inhibitors, sympathomimetics, calcium channel blockers, isoniazid (antibiotic for tuberculosis), insulin and glyburide or other medications for diabetes, and medications for thyroid disease.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to metformin contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
DO NOT take zonisamide if you have an allergy to sulfa drugs. A potentially fatal reaction can occur including a life threatening skin rash or a blood cell condition.
Before using zonisamide, tell your health care provider about your medical history, especially if you have:
Talk to your health care provider if you are planning to become pregnant or if pregnant or breastfeeding. Avoid alcohol and stay well hydrated while taking this medication. Do not drive, operate heavy machinery or perform any hazardous task until the effects of this medication are known to you. Tell your health care provider right away if you experience eye pain, changes in vision, eye swelling or redness, yellowing of the eyes, confusion, difficulty concentrating, suicidal thoughts, memory problems, trouble thinking clearly, agitation, irritability, speech problems, decreased sweating, sudden flank pain, painful urination, dark urine, increased fatigue, skin rash, faintness, easy bruising, irregular or fast heartbeat, bone pain, rapid breathing, dizziness, or stomach pain that is severe or that lasts more than a few days.
Many people experience no side effects while taking zonisamide. The most common side effects of zonisamide include:
Other possible side effects include:
These symptoms may subside after your body adjusts to the medication.
As with other medications, zonisamide can interact with certain medications, including carbonic anhydrase inhibitors (such as acetazolamide), orlistat (if using zonisamide for a seizure disorder), phenobarbital, primidone, rifamycins, glucocorticoids, and St. John's wort.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information. Do not stop taking this medication without consulting your healthcare provider because some conditions may become worse when the drug is suddenly stopped.
To report suspected adverse reactions to zonisamide contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
Before using topiramate, tell your health care provider about your medical history, especially if you have:
Topiramate may cause some people to sweat less. It is recommended to avoid alcohol and stay well hydrated while taking this medication.This drug may make you dizzy or drowsy or impair your judgment. Please do not drive, operate heavy machinery, or perform any hazardous task until the effects of topiramate are known to you. For anyone taking diabetes medications, please have a discussion with your prescribing clinician prior to taking topiramate as your diabetes medications may need to be adjusted as you lose weight.
Topiramate may also cause birth defects (particularly there is a risk of cleft lip and/or palate and low birth weight). Topiramate may cause breakthrough bleeding. DO NOT take topiramate if you are planning to become pregnant or if pregnant or breastfeeding.
Many people experience no side effects while taking topiramate. Some of the most common side effects (but not extremely frequent) are:
Additional side effects include:
These symptoms may subside after the body adjusts to the medication.
As with other medications, topiramate can interact with alcohol, marijuana and certain medications, including antiepileptic drugs, CNS depressants, oral contraceptives, lithium, other carbonic anhydrase inhibitors, hydrochlorothiazide, pioglitazone and amitriptyline. Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to topiramate contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.